NCT03790683

Brief Summary

The aim of this study is to assess the effectiveness of EnsoETM as a supplemental warming device compared to the standard of care warming practice in patients having major surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 27, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 2, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

February 11, 2019

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
11 months until next milestone

Results Posted

Study results publicly available

October 27, 2022

Completed
Last Updated

February 21, 2023

Status Verified

January 1, 2023

Enrollment Period

2.5 years

First QC Date

December 27, 2018

Results QC Date

September 6, 2022

Last Update Submit

January 30, 2023

Conditions

Keywords

intraoperative hypothermiainadvertent hypothermiaperioperative hypothermia

Outcome Measures

Primary Outcomes (1)

  • Inadvertent Hypothermia Prevention

    Number of degree-hours spent below 37 °C intraoperatively until recovery in the PACU and return to 37°C body temperature.

    Time from intubation until extubation, approximately 3-12 hours

Secondary Outcomes (1)

  • Time From Intubation Until Extubation

    perioperative, approximately 3-12 hours

Study Arms (2)

EnsoETM

EXPERIMENTAL

Participants receive esophageal warming. Original study design anticipated esophageal warming in addition to standard of care surface warming from the time they enter the OR until released to the PACU. After 7 patients, protocol was adjusted to specify only esophageal warming unless addition of surface warming was warranted.

Device: EnsoETMDevice: Surface Warming

Standard of Care

ACTIVE COMPARATOR

Participants receive standard of care surface warming from the time they enter the OR until released to the PACU.

Device: Surface Warming

Interventions

EnsoETMDEVICE

Patients having major surgery will have the EnsoETM device placed after induction of general anesthesia. Addition of standard of care surface warming was specified as optional after first 7 patients.

Also known as: ECD02, Esophageal Cooling Device
EnsoETM

Forced air warming device will be placed on the patient according to standard practice.

Also known as: Bair Hugger, forced air blanket
EnsoETMStandard of Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Provision of signed and dated informed consent form
  • Male or female, ages 18 years and older
  • Scheduled for major surgical procedures requiring general anesthesia and with no known contraindication to having an orogastric tube placed for the duration of the surgery
  • The time in the OR is expected to last at least 180 minutes

You may not qualify if:

  • Esophageal strictures (risk of perforation)
  • Patients with known esophageal deformity or evidence of esophageal trauma (for example history of esophagectomy, previous swallowing disorders, achalasia, etc.)
  • Known ingestion of acidic or caustic poisons within the prior 24 hours.
  • Patients with \<40 kg of body mass
  • Coagulopathy
  • Severe facial trauma
  • Surgical procedures lasting less than 3 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

Location

MeSH Terms

Conditions

Hypothermia

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Marc C. Torjman, Ph.D.
Organization
Sidney Kimmel Medical College, Thomas Jefferson University and Hospitals

Study Officials

  • Coleen Vernick, DO

    Thomas Jefferson University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: prospective, randomized interventional study
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 27, 2018

First Posted

January 2, 2019

Study Start

February 11, 2019

Primary Completion

August 1, 2021

Study Completion

December 1, 2021

Last Updated

February 21, 2023

Results First Posted

October 27, 2022

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations